Skip to main content
OpenTrials

Clinical trial condition

Non-Hodgkin Lymphoma

Explore clinical trials studying Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

219 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Non-Hodgkin Lymphoma trial results

Active, not recruiting

Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors

NCT06002828

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 507 locations
View Trial Details
Active, not recruiting

Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab

NCT05206357

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +15 more
Locations
  • Lucile Packard Children's Hospital /ID# 240854 Palo Alto, California, United States
  • Nicklaus Children's Hospital /ID# 241174 Miami, Florida, United States
  • New York Medical College /ID# 239208 Valhalla, New York, United States
  • Levine Children's Hospital /ID# 242765 Charlotte, North Carolina, United States
View all 41 locations
View Trial Details
Active, not recruiting

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies

NCT05207670

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Infirmary Cancer Care Mobile, Alabama, United States
  • Alaska Oncology & Hematology, LLC Anchorage, Alaska, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
View all 39 locations
View Trial Details
Active, not recruiting

A Study to Assess Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide in Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma

NCT05950165

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Tri-Service General Hospital - Neihu Branch - Hematology Taipei, Taiwan
  • Taipei Medical University - Shuang Ho Hospital - Oncology New Taipei City, Taipei Special Municipality, Taiwan
  • National Taiwan University Hospital Yunlin Branch Huwei, Taiwan
  • Chi-Mei Medical Center Tainan, Taiwan
View Trial Details
Active, not recruiting

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma

NCT05169515

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • UCSF/Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program San Francisco, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The University of Chicago Chicago, Illinois, United States
View all 25 locations
View Trial Details
Active, not recruiting

A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

NCT05171647

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • St. Luke's Hospital Chesterfield, Missouri, United States
  • Ascension Seton Infusion Center Austin, Texas, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View all 51 locations
View Trial Details
Active, not recruiting

Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant

NCT02506933

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +43 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions